Oral vaccine delivery: can it protect against non-mucosal pathogens? - Test2 - elhamkhani - TriplyDB

Oral vaccine delivery: can it protect against non-mucosal pathogens?

Oral vaccine delivery: can it protect against non-mucosal pathogens?

http://www.wikidata.org/entity/Q37229915

about

Vaccines: the Fourth Century Therapeutic and prevention strategies against human enterovirus 71 infection On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects?Humanized HLA-DR4 mice fed with the protozoan pathogen of oysters Perkinsus marinus (Dermo) do not develop noticeable pathology but elicit systemic immunity.The success of microneedle-mediated vaccine delivery into skin.Construction and evaluation of a fluorescence-based live attenuated Escherichia coli delivery system for generating oral vaccine candidate.Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate.Evaluation of plant-produced <i>Clostridium perfringens</i> type D <i>epsilon</i> toxoid in a vaccine against enterotoxaemia in sheep.Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate

P2860

Q27490454-4B178155-719E-4C88-B6CC-772FBFD26203 Q28080796-326E837F-9FB4-473A-B1DB-382AA8F6DB4A Q35002326-AF9594A5-31F6-4B8D-B3EF-3165348E7AD0 Q36590168-AD752736-E7B4-48C1-9D4D-729AA8C59547 Q37538745-9E7F9E04-A54F-44DE-B3E0-67C4146F8AA5 Q38799509-CDB59A42-9619-42F5-B716-F61F4BC3DCE3 Q39063059-E21C7ED6-D5BF-4461-85C1-A76BC8BF2B8F Q49920855-7131E304-B57B-4C8B-86E8-53D7E2D29B29 Q51021392-EB93D2D9-E4E6-4120-BB34-80C6FE2EB9BF Q58740569-A8CF0A62-F639-43EE-B809-8619B46E648A

P2860

Oral vaccine delivery: can it protect against non-mucosal pathogens?

http://www.wikidata.org/entity/Q37229915

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Oral vaccine delivery: can it protect against non-mucosal pathogens?

@en

Oral vaccine delivery: can it protect against non-mucosal pathogens?

@nl

type

label

Oral vaccine delivery: can it protect against non-mucosal pathogens?

@en

Oral vaccine delivery: can it protect against non-mucosal pathogens?

@nl

prefLabel

Oral vaccine delivery: can it protect against non-mucosal pathogens?

@en

Oral vaccine delivery: can it protect against non-mucosal pathogens?

@nl

P1433

Q37229915-5884E439-D2C4-4049-A308-8D3F2C73FF5F

P1476

Q37229915-FDBC4470-249E-4286-917B-D3999F754114

P2093

Q37229915-FB1E2A14-1993-440A-B7C8-08428C1160D4

P2860

Q37229915-007C8EEC-0DE2-4E21-89D7-BF0FD726689F

Q37229915-04FA0C3D-D6A3-4625-84CA-D8BDC2A7972E

Q37229915-05CE7158-3045-4F88-8C79-21D92C832459

Q37229915-09E059FE-8DA7-460D-B46B-07D0C2A7DEF8

Q37229915-0AD44535-4AE0-43A1-A36C-4BF0DA605EFF

Q37229915-10CB4E92-948E-411E-846A-A40D559171C0

Q37229915-1603E946-800F-421A-8D1D-B3A6FE9D48F0

Q37229915-1C30BD8B-93A5-4CFD-AB94-AA48748C53D7

Q37229915-24AD2ACA-B081-405C-8015-97B6A9511FED

Q37229915-24E65DED-AF09-46FD-858E-1E2B3EFA2A95

P304

Q37229915-386E8109-1D1F-4AD4-BB0A-6FC47464EEF6

P31

Q37229915-4BCC46DB-9F0D-445F-86D2-D038AF827153

P356

Q37229915-2424AAC8-4A73-48D7-A40A-91EF4F467C6D

P433

Q37229915-BFCFD11B-C0CF-4E2D-8692-1042AD1C0143

P478

Q37229915-074AC1EC-A9BD-4873-AD7E-47C897F4A026

P50

Q37229915-7C337B98-6F50-465C-B7EB-5EDA6B4ADC85

P577

Q37229915-307DF914-CEA4-4FCB-A587-F63809845A48

P5875

Q37229915-AA050A71-3323-4779-8A14-0E82D5C919D2

P698

Q37229915-7B9DB8ED-2B1F-464C-9662-2C0C717BE5C7

P356

14760584.7.6.729

P1433

Expert Review of Vaccines

P1476

Oral vaccine delivery: can it protect against non-mucosal pathogens?

@en

P2093

Lina Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

Viral vectors for the expression of proteins in plants.

Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.

Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL

The vaccine is dead--long live the vaccine.

Immunogenicity in humans of an edible vaccine for hepatitis B.

Oral immunization with hepatitis B surface antigen expressed in transgenic plants.

Vaccination strategies for mucosal immune responses

P304

729-738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.7.6.729

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23136226

http://www.w3.org/2001/XMLSchema#string

P698

18665772

http://www.w3.org/2001/XMLSchema#string